A new analysis from The New York Times, along with German outlets NDR and WDR, took a closer look at the administration’s new drug pricing platform, TrumpRx. What they found is that while some prices have come down, Americans are still paying significantly more than patients in other wealthy countries,
Admin touts TrumpRX success: it’s a quick fix, not real progress!
Originally reported by The Hill
Related Articles
5 Things to Know About Paul LePage, Republican House Candidate in Maine
Mr. LePage served two terms as governor of Maine and was known for his incendiary rhetoric and his vetoing of legislatio...
House defies Johnson and passes Democratic-led labor bill
Twenty G.O.P lawmakers broke with Speaker Mike Johnson and joined Democrats in backing a bill to amend the National Labo...
Faster Labor Contracts Act passes House after GOP rebels join Democrats
The House on Tuesday passed the Faster Labor Contracts Act, a bill that seeks to impose shorter timelines for first-cont...
5 Things to Know About Graham Platner, Democratic Senate Candidate in Maine
Mr. Platner, an oyster farmer running for a Senate seat on a progressive platform, has drawn a large following among Dem...